COPAXONE 40 · TEV-ACE-2015-01

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

Spanish registry of patients treated with glatiramer acetate (Copaxone®) 40 mg/mL

Sponsor: TEVA

Phase: IV

Area: Neuroimmunology

Open the current study catalogue